Current Medicinal Chemistry

Polyamines in the Brain: Distribution, Biological Interactions, and their Potential Therapeutic Role in Brain Ischaemia
pp. 1807-1813(7)
Authors: Jun Li,; Karen M. Doyle,; Turgut Tatlisumak,

Therapeutic Targets in the ARF Tumor Suppressor Pathway
pp. 1815-1827(13)
Authors: Anthony J. Saporita,; Leonard B. Maggi,; Anthony J. Apicelli,; Jason D. Weber,

Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes
pp. 1829-1852(24)
Authors: Claudio Viegas-Junior,; Amanda Danuello,; Vanderlan da Silva Bolzani,; Eliezer J. Barreiro,; Carlos Alberto Manssour Fraga,

Hydroxylation of Hypoxia-Inducible Transcription Factors and Chemical Compounds Targeting the HIF-α Hydroxylases
pp. 1853-1862(10)
Authors: K. Bruegge,; W. Jelkmann,; E. Metzen,

Whither Combine? New Opportunities for Receptor-Based QSAR
pp. 1863-1877(15)
Authors: Gerald H. Lushington,; Jian-Xin Guo,; Jenna L. Wang,

Uric Acid Reduction: A New Paradigm in the Management of Cardiovascular Risk?
pp. 1879-1886(8)
Authors: Jesse Dawson,; Terry Quinn,; Matthew Walters,

Relevance of Endothelial-Haemostatic Dysfunction in Cigarette Smoking
pp. 1887-1892(6)
Authors: Rossella R. Cacciola,; Francesca Guarino,; Riccardo Polosa,

Mechanism and Potential of the Growth-Inhibitory Actions of Vitamin D and Analogs
pp. 1893-1910(18)
Authors: G. Eelen,; C. Gysemans,; L. Verlinden,; E. Vanoirbeek,; P. De Clercq,; D. Van Haver,; C. Mathieu,; R. Bouillon,; A. Verstuyf,